References
- Riehl, B. D., Kim, E., Bouzid, T. & Lim, J. Y. The role of
microenvironmental cues and mechanical loading milieus in breast
cancer cell progression and metastasis. Frontiers in
Bioengineering and Biotechnology 8, (2021).
- Tse, J. M. et al. Mechanical compression drives cancer cells
toward invasive phenotype. Proceedings of the National Academy
of Sciences 109, 911–916 (2011).
- Romani, P., Valcarcel-Jimenez, L., Frezza, C. & Dupont, S. Crosstalk
between mechanotransduction and metabolism. Nature Reviews
Molecular Cell Biology 22, 22–38 (2020).
- Levental, K. R. et al. Matrix crosslinking forces tumor
progression by enhancing integrin signaling. Cell 139,891–906 (2009).
- Jang, M. et al. Matrix stiffness epigenetically regulates the
oncogenic activation of the yes-associated protein in Gastric cancer.Nature Biomedical Engineering 5, 114–123 (2020).
- Vasudevan, J., Lim, C. T. & Fernandez, J. G. Cell migration and
breast cancer metastasis in biomimetic extracellular matrices with
independently tunable stiffness. Advanced Functional Materials30, 2005383 (2020).
- Panciera, T. et al. Reprogramming normal cells into tumour
precursors requires ECM stiffness and oncogene-mediated changes of
cell mechanical properties. Nature Materials 19,797–806 (2020).
- Derkus, B. et al. Multicomponent hydrogels for the formation of
vascularized bone-like constructs in vitro. Acta Biomaterialia109, 82–94 (2020).
- Rezaeeyazdi, M., Colombani, T., Eggermont, L. J. & Bencherif, S. A.
Engineering hyaluronic acid-based cryogels for CD44-mediated breast
tumor reconstruction. Materials Today Bio 13, 100207
(2022).
- Loebel, C., D’Este, M., Alini, M., Zenobi-Wong, M. & Eglin, D.
Precise tailoring of tyramine-based hyaluronan hydrogel properties
using DMTMM conjugation. Carbohydrate Polymers 115,325–333 (2015).
- Isik, M. et al. Mechanically robust hybrid hydrogels of
photo-crosslinkable gelatin and laminin-mimetic peptide amphiphiles
for neural induction. Biomaterials Science 9,8270–8284 (2021).
- D’Souza, A. M. et al. Small molecule CJOC42 improves
chemo-sensitivity and increases levels of tumor suppressor proteins in
hepatoblastoma cells and in mice by inhibiting oncogene gankyrin.Frontiers in Pharmacology 12, (2021).
- Acerbi, I. et al. Human breast cancer invasion and aggression
correlates with ECM stiffening and immune cell infiltration.Integrative Biology 7, 1120–1134 (2015).
- Wei, S. C. et al. Matrix stiffness drives
epithelial–mesenchymal transition and tumour metastasis through a
twist1–G3BP2 mechanotransduction pathway. Nature Cell Biology17, 678–688 (2015).
- Yuan, Y., Zhong, W., Ma, G., Zhang, B., Tian, H. Yes-associated
protein regulates the growth of human non-small cell lung cancer in
response to matrix stiffness. Molecular Medicine Reports11, 4267–4272 (2015).
- Krndija, D. et al. Substrate stiffness and the receptor-type
tyrosine-protein phosphatase alpha regulate spreading of colon cancer
cells through cytoskeletal contractility. Oncogene 29,2724–2738 (2010).
- Li, Y. & Kumacheva, E. Hydrogel microenvironments for cancer spheroid
growth and drug screening. Science Advances 4, (2018).
- Zanconato, F., Cordenonsi, M. & Piccolo, S. Yap and Taz: A signalling
hub of the tumour microenvironment. Nature Reviews Cancer19, 454–464 (2019).
- Lee, J. Y. et al. Yap-independent mechanotransduction drives
breast cancer progression. Nature Communications 10,(2019).
- Yuan, M. et al. Yes-associated protein (YAP) functions as a
tumor suppressor in breast. Cell Death & Differentiation15, 1752–1759 (2008).
- Scott, K. E., Fraley, S. I. & Rangamani, P. A spatial model of
yap/taz signaling reveals how stiffness, dimensionality, and shape
contribute to emergent outcomes. Proceedings of the National
Academy of Sciences 118, (2021).
- Cordenonsi, M. et al. The hippo transducer taz confers cancer
stem cell-related traits on breast cancer cells. Cell147, 759–772 (2011).
- Lahlou, H. et al. Mammary epithelial-specific disruption of the
focal adhesion kinase blocks mammary tumor progression.Proceedings of the National Academy of Sciences 104,20302–20307 (2007).
- Yue, X. et al. Leukemia inhibitory factor drives glucose
metabolic reprogramming to promote breast tumorigenesis. Cell
Death & Disease 13, (2022).
- Han, J., Li, Q., Chen, Y. & Yang, Y. Recent metabolomics analysis in
tumor metabolism reprogramming. Frontiers in Molecular
Biosciences 8, (2021).
- Warburg, O. On respiratory impairment in cancer cells. Science124, 269–270 (1956).
- Wei, Z., Liu, X., Cheng, C., Yu, W. & Yi, P. Metabolism of amino
acids in cancer. Frontiers in Cell and Developmental Biology8, (2021).
- Koundouros, N. & Poulogiannis, G. Reprogramming of fatty acid
metabolism in cancer. British Journal of Cancer 122,4–22 (2019).
- Fong, M. Y. et al. Breast-cancer-secreted Mir-122 reprograms
glucose metabolism in premetastatic niche to promote metastasis.Nature Cell Biology 17, 183–194 (2015).
- Hannun, Y. A. & Obeid, L. M. Sphingolipids and their metabolism in
physiology and disease. Nature Reviews Molecular Cell Biology19, 175–191 (2017).
- Martínez-Reyes, I. & Chandel, N. S. Mitochondrial TCA cycle
metabolites control physiology and disease. Nature
Communications 11, (2020).
- Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C. & Fukumura,
D. Arginine dependence of tumor cells: Targeting a chink in cancer’s
armor. Oncogene 35, 4957–4972 (2016).
- Tönjes, M. et al. BCAT1 promotes cell proliferation through
amino acid catabolism in gliomas carrying wild-type IDH1. Nature
Medicine 19, 901–908 (2013).
- Sun, L., Zhang, H. & Gao, P. Metabolic reprogramming and epigenetic
modifications on the path to cancer. Protein & Cell13, 877–919 (2021).
- Son, J. et al. Glutamine supports pancreatic cancer growth
through a KRAS-regulated metabolic pathway. Nature496, 101–105 (2013).
- Ullah Khan, S. & Ullah Khan, M. The role of amino acid metabolic
reprogramming in tumor development and immunotherapy.Biochemistry and Molecular Biology 7, 6 (2022).
- Li, Y. et al. Matrix stiffness regulates chemosensitivity,
stemness characteristics, and autophagy in breast cancer cells.ACS Applied Bio Materials 3, 4474–4485 (2020).
- Morandi, A. & Indraccolo, S. Linking metabolic reprogramming to
therapy resistance in cancer. Biochimica et Biophysica Acta
(BBA) - Reviews on Cancer 1868, 1–6 (2017).
- Germain, N. et al. Lipid metabolism and resistance to
anticancer treatment. Biology 9, 474 (2020).
- Yoo, H.-C. & Han, J.-M. Amino acid metabolism in cancer drug
resistance. Cells 11, 140 (2022).